Antifungal Agents
Cryptococcal Meningitis
Healthcare Associated Infections II: Preventive Measures
Candidiasis
Antiprotozoal Agents
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Olivier Paccoud1, Simon Feys2, Sarah Dellière3
1Infectious Diseases Department, Necker-Enfants Malades Hospital, AP-HP, Paris, France; Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
No abstract available in PubMed .